biotech · Non-Small Cell Lung Cancer · Pneumococcal Vaccines · MAIA
MAIA Biotechnology
Makai Biotechnology is a biotech organization headquartered in honolulu, USA. It trades on NYSE under ticker MAIA. Primary therapeutic focus areas include Non-Small Cell Lung Cancer, Pneumococcal Vaccines, Carcinoma, Non
Company details
- Status
- Public
- HQ
- honolulu, USA
- Founded
- 2013
- Employees
- 5
- Programs
- 8
- Drugs
- 19
- Patents
- 10
Quick answer
Makai Biotechnology is a biotech organization headquartered in honolulu, USA. It trades on NYSE under ticker MAIA. Primary therapeutic focus areas include Non-Small Cell Lung Cancer, Pneumococcal Vaccines, Carcinoma, Non-Small-Cell Lung, Resectable Hepatocellular Carcinoma, Alzheimer Blood Biomarkers. NovaPharmaNews links 8 clinical program(s), 4 drug profile(s), and 10 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (3), phase 2 (2), phase 1 (2).
Company snapshot
Makai Biotechnology is based in based in Honolulu, Hawaii, USA and specializes in the clinical development of therapeutics. Major projects include, the development of a novel therapeutics for the treatment of cardiac hypertrophy, heart failure and associated pathologies.
- 6 approved product(s) across US/EU regulatory metadata.
- 8 active pipeline program(s) linked via ClinicalTrials.gov.
- 10 US patent(s) indexed to this assignee profile.
Public regulatory, clinical, patent, and corporate records for MAIA Biotechnology. Not investment advice.
Catalysts
Upcoming readouts, regulatory dates, and congress activity.
- approval
FDA clears U.S. trial of MAIA lung cancer drug for third-line patients
Recent coverage
Top assets
Lead pipeline drugs
- Marketed / approved
- Marketed / approved
- approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 2
Momentum
Proprietary activity score for MAIA Biotechnology.
2 active signals
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for MAIA Biotechnology.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is MAIA Biotechnology?
-
Is MAIA Biotechnology publicly traded?
-
What drugs does MAIA Biotechnology develop or market?
-
What are the latest developments for MAIA Biotechnology?
-
What therapeutic areas does MAIA Biotechnology focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.